HIV/AIDS
-
June 18, 2021
The whitewater trip was a disaster. It motivated Renée Garside to become an expert kayaker.
There’s no doubt she loves it, especially when she says things like: “I just love it, love it, love it.” -
March 18, 2021
HIV, diabetes and immune cells in fat
In HIV-positive individuals with diabetes, immune cells in fat are more proinflammatory and cytotoxic and may represent a therapeutic target for diabetes. -
March 4, 2021
Clinic helps prepare young HIV patients for adult care
Adolescents and young adults living with HIV in Middle Tennessee are being ushered into adult care through a special transition clinic that focuses on adult skill-building and individualized therapy and discussions. -
February 18, 2021
VUMC investigator expands HIV research into South Africa
A Vanderbilt University Medical Center investigator is hoping to improve access to HIV testing in South Africa, where more than 7 million people are known to have the virus, by training traditional healers to perform the tests. -
February 11, 2021
Clinical Trials Unit lands major grant renewal
Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis have received renewal of a major federal grant to continue their collaboration to test and develop new treatments and vaccines against HIV/AIDS — and now COVID-19. -
February 8, 2021
Key factors in HIV-1 replication
HIV-1, the virus that causes AIDS, exploits inositol phosphates in T cells to aid its own assembly and maturation — suggesting that targeting inositol phosphate binding could inhibit HIV-1 replication. -
December 10, 2020
HIV patients stay away after Nigerian clinic introduces fees
Six years ago, in Nigeria, funding cutbacks for HIV treatment and the consequent introduction of patient fees were associated with sharp declines in new HIV clinic enrollments and patient adherence to antiretroviral therapy (ART).